Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula Zwicker has a total of 155 co-authors. Here are the top co-authors by number of shared publications:

  • Axel Kramer

    Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, 17475, Greifswald, Germany

    5 shared publications
  • Axel Kramer

    University Medicine Greifswald

    5 shared publications
  • A. Kramer

    Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany

    2 shared publications
  • Gerald Müller

    Institute of Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Str., University Medicine, D-17475 Greifswald, Germany

    2 shared publications
  • Gerald Müller

    Institute of Hygiene and Environmental Medicine, University Medicine, Ferdinand-Sauerbruch-Straße, D-17475 Greifswald, Germany

    2 shared publications
  • Melanie Hornschuh

    Institute of Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Str., University Medicine, D-17475 Greifswald, Germany

    2 shared publications

Latest Publications

  • Open Access

    +A CAR T cell-amplified suppressive B cell circuit in AML

    by Adrian Gottschlich, Vladyslav Kavaka, Thomas Alexander Janert, Veronika Igl, Emanuele Carlini, Lisa Rohrbacher, Wendy Den Hartog, Jakob Harwood, Marcel P. Trefny, Selin Sogukcelik, et al.

    Immunotherapy in acute myeloid leukemia (AML) is constrained by a hostile bone marrow niche. Here we identify atypical memory B cells (B atyp ) as a suppressive population within this microenvironment. Across single cell and flow cytometry cohorts, B atyp were expanded in AML, and their molecular and phenotypic profiles resembled those of atypical B cells associated with chronic inflammatory conditions. B atyp were polarized within the AML microenvironment, and this was amplified by CAR T cell–AML interactions. Mechanistically, polarization was dependent on Toll-like receptor, interferon and CD70–CD27 signaling. B atyp suppressed T cell and CAR T cell responses via PD-1-and TGF-β-R signaling, and were enriched in non-responding patients with AML and myeloma. CD180-directed CAR T cells, targeting an antigen shared by B atyp and AML blasts, resisted suppression in vitro and cleared disease in B cell–humanized xenografts while sparing hematopoietic stem cells, with B cell engagement further enhancing their expansion. CAR T cells thus reinforce their own suppressive niche through B atyp polarization, a constraint that can be relieved by dual blast- and B cell-targeting strategies.

  • Open Access

    233 nm far‐ UV ‐C radiation for biofilm inactivation

    by Paula Zwicker, Antonia Maja Lotta Bradtke, Neysha Lobo Ploch, Nils‐Olaf Hübner

    The formation of biofilms protects bacteria from antibiotic therapy or disinfection based on different mechanisms. The treatment of biofilms is furthermore impeded by their characteristic of being composed of multiple species; thus, it is necessary to identify involved species to determine an appropriate treatment. Consequently, new methods for inactivating involved bacteria in biofilms are necessary. One possibility might be the use of skin‐compatible doses of 233 nm far‐UV‐C irradiation. In the presented study, the potential for biofilm formation of various bacteria species and strains was identified using a plate‐based assay (crystal violet staining) as well as two cultivation‐based assays on agar plates (Congo red, calcofluor). Strains of S. aureus , S. epidermidis , and P. aeruginosa were selected and grown on stainless steel carriers for 24 h followed by irradiation with skin‐tolerable doses of 233 nm far‐UV‐C radiation (20–80 mJ/cm 2 ). Viability of bacteria was assessed via quantification of colony‐forming units. Irradiation led to a statistically significant inactivation of up to 2.28 lg ( S. epidermidis ), 2.60 lg ( S. aureus ), and 1.16 lg ( P. aeruginosa ). Higher doses tended to result in slightly higher inactivation, but without statistical significance. Since UV‐C irradiation does not remove bacteria and the surrounding matrix, additional cleansing is necessary for biofilm removal. But UV‐C irradiation can be an effective addition to cleansing and chemical treatment for biofilm inactivation. Therefore, for potential applications on skin or mucous membranes, UV‐C currently represents a valuable additional method that broadens the antiseptic treatment repertoire.

  • Open Access

    In vitro efficacy of aqueous PVP-iodine solution below 5% as alternative to preoperative antisepsis in ophthalmology as the basis for an in vivo study

    by Paula Zwicker, Nevin Opitz, Julia Harris, Andreas Stahl, Ulrich Kellner, Ruth Koelb-Keerl, Philipp S. Muether, Anne Hunold, Axel Kramer

    Purpose: Pre-operative antisepsis of the conjunctiva is indicated prior to intraocular surgery to prevent post-interventional endophthalmitis. In Germany, antisepsis with 5% povidone-iodine (PI) aqueous solution is explicitly required prior to intravitreal injections (IVI), and also generally recommended for intraocular surgery. However, this concentration often leads to a foreign body sensation and an unpleasant burning in combination with dry eye symptoms. Postoperative eye pain, persistent corneal epithelial defects, and a risk of keratitis are further side effects. Due to the repetitive nature of IVI, these symptoms are particularly present in IVI patients. A reduced concentration may be favorable to decrease patient discomfort. A 1.25% PI solution does not increase the iodine concentration in the aqueous humor and is also used for prophylaxis of ophthalmia neonatorum and for preoperative antisepsis; in both cases the renal iodine excretion stays in a physiological range thus thyroid diseases are no contraindication for its use. Thus, the efficacy of reduced concentrations of PI should be evaluated in vitro. Methods: PI with dilutions below 5% (0.625 − 2.5% serial 1:2 dilution) was tested in vitro in a quantitative suspension assay and in a quantitative carrier test without and with addition of matrices to identify their antimicrobial effect against Staphylococcus epidermidis, Pseudomonas aeruginosa, Cutibacterium acnes and Candida albicans. Results: No differences in the antimicrobial effect was seen due to reduced concentrations of PI in comparison to a 5% solution. However, a trend was seen regarding the required contact time of the antiseptic solution. Conclusion: The in-vitro tests have shown adequate antisepsis of 1.25% PI prior to intraocular surgery. However, it is important to pay attention to a sufficient contact time of the antiseptic of about 1 min before ophthalmologic intervention. In order to give final recommendations, in vivo testing is needed to build a robust data foundation.


  • Open Access

    A biocompatible polylactide-ε-caprolactone polymer coated with poly(hexamethylene biguanide) displays antibacterial properties against slime-producing S. epidermidis

    by Paula Zwicker, Melanie Hornschuh, Thomas Schmidt, Jan Schäfer, Carsten Becker-Willinger, Marlon Jochum, Axel Kramer, Gerald Müller

    Introduction: produced by renewable resources, biodegradable polymers with their competitive mechanical properties, thermal stability and biocompatibility are important alternatives to other synthetic materials for use in medical devices, i.e. endotracheal suction catheters. However, infected catheters may lead to nosocomial infections, such as lower respiratory tract infections, with mechanical ventilation being a major risk for these. Antimicrobially coated endotracheal suction catheters may be one measure to reduce this risk. Methods: two procedures using ethanol and sodium hydroxide were tested to immobilize poly(hexamethylene biguanide) (PHMB) to polylactide-ε-caprolactone (PLA-ε-CL). The cytocompatibility of the coating was verified via the MTT assay and cytokine analysis in a cell monolayer and in a 3D mucosa model. The antimicrobial efficacy was tested using S. epidermidis; after this bacterial contamination and the adherence and viability of cells were tested. Chemical surface analysis has been performed with pristine and PHMB-coated specimens by means of infrared spectroscopy (ATR-FTIR). Results: with both applied coating procedures, PHMB could be immobilized onto the PLA-ε-CL surface. The biocompatibility of PLA-ε-CL was not impaired by the PHMB coating. IL-1α was slightly but significantly increased. Reduction of S. epidermidis was about 4 lg-levels after 6 h of incubation. Contamination of the surface prior to cell culture did not impair the adherence of the cells. Conclusion: we demonstrated that PLA-ε-CL coated with PHMB has good biocompatible properties with antimicrobial activity thus revealing the polymer to be a suitable material for the development of medical devices that are able to prevent bacterial contaminations and infections.


  • Open Access

    Studies on the Virucidal Effects of UV-C of 233 nm and 275 nm Wavelengths

    by Jessica Kohs, Tom Lichtenthäler, Carolyn Gouma, Hyun Kyong Cho, Andreas Reith, Axel Kramer, Sven Reiche, Paula Zwicker

    Among the physical decontamination methods, treatment with ultraviolet (UV) radiation is a suitable means of preventing viral infections. Mercury vapor lamps (254 nm) used for room decontamination are potentially damaging to human skin (radiation) and harmful to the environment (mercury). Therefore, other UV-C wavelengths (100–280 nm) may be effective for virus inactivation on skin without damaging it, e.g., far-UV-C radiation with a wavelength of 233 nm, which is absorbed in the outer layer of the skin and thus does not reach the deeper layers of the skin. For room disinfection, 275 nm UV-C LED lamps could be a more environmentally friendly alternative, since toxic mercury is avoided. A carrier test using multiple viruses was used to determine the TCID50/mL value on stainless steel, PVC, and glass carriers. In addition to the inactivation kinetics (233 nm), the necessary UV-C dose for 4 lg inactivation (275 nm) was investigated. The impact of irradiance on the inactivation efficacy was also assessed. The inactivation of the viruses was a function of the radiation dose. UV-C-radiation at 233 nm (80 mJ/cm2) inactivated from 1.49 ± 0.08 to 4.28 ± 0.18 lg depending on the virus used. To achieve a 4 lg inactivation (275 nm) for enveloped viruses, doses of up to 70 mJ/cm2 (SuHV-1) were sufficient. For non-enveloped viruses, a maximum dose of 600 mJ/cm2 (MS2) was necessary. Enveloped viruses were inactivated with lower doses compared to non-enveloped viruses. Higher radiation doses were required for inactivation at 275 nm in comparison to 254 nm. A more environmentally friendly alternative to mercury vapor lamps is available with 275 nm LED emitters. Radiation at 233 nm could serve as an additional prophylactic or therapeutic measure for virus inactivation in direct contact with human skin.


  • Open Access

    No detrimental effect on the hand microbiome of health care staff by frequent alcohol-based antisepsis

    by Axel Kramer, Mathilde Borg Dahl, Mia M. Bengtsson, John M. Boyce, Matthias Heckmann, Mareike Meister, Roald Papke, Didier Pittet, Anne Reinhard, Hortense Slevogt, et al.


  • Open Access

    Efficacy of 233 nm LED far UV-C-radiation against clinically relevant bacterial strains in the phase 2/ step 2 in vitro test on basis of EN 14561 and on an epidermis cell model

    by Claudia Sicher, Nevin Opitz, Pia Elen Becker, Neysha Lobo Ploch, Johannes Schleusener, Michael Kneissl, Axel Kramer, Paula Zwicker


  • Open Access

    Suitable Disinfectants with Proven Efficacy for Genetically Modified Viruses and Viral Vectors

    by Maren Eggers, Ingeborg Schwebke, Johannes Blümel, Franziska Brandt, Helmut Fickenscher, Jürgen Gebel, Nils Hübner, Janis A. Müller, Holger F. Rabenau, Ingrid Rapp, et al.

    Viral disinfection is important for medical facilities, the food industry, and the veterinary field, especially in terms of controlling virus outbreaks. Therefore, standardized methods and activity levels are available for these areas. Usually, disinfectants used in these areas are characterized by their activity against test organisms (i.e., viruses, bacteria, and/or yeasts). This activity is usually determined using a suspension test in which the test organism is incubated with the respective disinfectant in solution to assess its bactericidal, yeasticidal, or virucidal activity. In addition, carrier methods that more closely reflect real-world applications have been developed, in which microorganisms are applied to the surface of a carrier (e.g., stainless steel frosted glass, or polyvinyl chloride (PVC)) and then dried. However, to date, no standardized methods have become available for addressing genetically modified vectors or disinfection-resistant oncolytic viruses such as the H1-parvovirus. Particularly, such non-enveloped viruses, which are highly resistant to disinfectants, are not taken into account in European standards. This article proposes a new activity claim known as “virucidal activity PLUS”, summarizes the available methods for evaluating the virucidal activity of chemical disinfectants against genetically modified organisms (GMOs) using current European standards, including the activity against highly resistant parvoviridae such as the adeno-associated virus (AAV), and provides guidance on the selection of disinfectants for pharmaceutical manufacturers, laboratories, and clinical users.


  • Open Access

    Antiseptic efficacy of two mouth rinses in the oral cavity to identify a suitable rinsing solution in radiation- or chemotherapy induced mucositis

    by Paula Zwicker, Marcus Freitag, Florian H. Heidel, Thomas Kocher, Axel Kramer

    Objectives: Oral mucositis caused by intensive cancer chemotherapy or radiotherapy frequently results in pronounced damage of the oral mucosa leading to painful oral hygiene. To support oral care, antimicrobial effective mouth rinses may be used. Thus, the efficacy of a hypochlorite-based mouth rinse (Granudacyn®), assumed to be highly biocompatible because of the compounds being part of the natural pathogen defense, as possible antiseptic agent in case of oral mucositis was compared to that of an octenidine based antiseptic mouth rinse (Octenidol® md). Materials and methods: The study was conducted as monocentric, controlled, randomized, blind cross over comparative study on 20 volunteers. As a proof of principle, we performed the study on orally healthy subjects and not cancer patients. The efficacy was determined as reduction of colony forming units (cfu) on buccal mucosa as well as in saliva. After mouth rinsing for 30 s, samples were taken after 1 min, 15 min, 30 and 60 min. The lg-reduction was calculated as difference between lg-values of cfu pre- and post-treatment. Results: Both antiseptic mouth rinses induced a significant reduction of cfu on buccal mucosa and in saliva 1 min after mouth rinsing. The effect persisted up to 60 min. The octenidine based rinse was significantly superior to the hypochlorite-based rinse up to the last sample 60 min after rinsing. However, the known cytotoxicity of octenidine argues against its application. Conclusion: Within the limits of this study, due to its antiseptic efficacy, the hypochlorite-based rinse Granudacyn® can be regarded appropriate to support the oral hygiene in patients with a sensitive oral mucosa during an aggressive cancer chemotherapy and radiation treatment in case of oral mucositis.